• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成素-1和血管生成素-2在代谢紊乱中的作用:恢复糖尿病血管生成高低平衡的治疗策略

Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes.

作者信息

Isidori A M, Venneri M A, Fiore D

机构信息

Department of Experimental Medicine, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy.

出版信息

J Endocrinol Invest. 2016 Nov;39(11):1235-1246. doi: 10.1007/s40618-016-0502-0. Epub 2016 Jun 25.

DOI:10.1007/s40618-016-0502-0
PMID:27344309
Abstract

The morbidity and mortality of diabetes mellitus are mostly attributed to cardiovascular complications. Despite tremendous advancement in glycemic control, anti-diabetic medications have failed to revert vascular impairment once triggered by the metabolic disorder. The angiogenic growth factors, Angiopoietin-1 (Ang1) and Angiopoietin-2 (Ang2), are crucial regulators of vessel formation and maintenance starting with embryonic development and continuing through life. In mature vessels, angiopoietins control vascular permeability, inflammation and remodeling. A crucial role of angiopoietins is to drive vascular inflammation from the active to the quiescent state, enabling restoration of tissue homeostasis. The mechanism is of particular importance for healing and repair after damage, two conditions typically impaired in metabolic disorders. There is an emerging body of evidences suggesting that the imbalance of Ang1 and Ang2 regulation, leading to an increased Ang2/Ang1 ratio, represents a culprit of the vascular alterations of patients with type-2 diabetes mellitus. Pharmacological modulation of Ang1 or Ang2 actions may help prevent or delay the onset of diabetic vascular complications by restoring vessel function, favoring tissue repair and maintaining endothelial quiescence. In this review, we present a summary of the role of Ang1 and Ang2, their involvement in diabetic complications, and novel therapeutic strategies targeting angiopoietins to ameliorate vascular health in metabolic disorders.

摘要

糖尿病的发病率和死亡率主要归因于心血管并发症。尽管血糖控制取得了巨大进展,但抗糖尿病药物一旦由代谢紊乱引发血管损伤,就无法使其恢复。血管生成生长因子血管生成素-1(Ang1)和血管生成素-2(Ang2)是从胚胎发育开始直至生命全程中血管形成和维持的关键调节因子。在成熟血管中,血管生成素控制血管通透性、炎症和重塑。血管生成素的一个关键作用是将血管炎症从活跃状态转变为静止状态,从而使组织内环境稳定得以恢复。该机制对于损伤后的愈合和修复尤为重要,而这两种情况在代谢紊乱中通常会受损。越来越多的证据表明,Ang1和Ang2调节失衡,导致Ang2/Ang1比值升高,是2型糖尿病患者血管改变的罪魁祸首。对Ang1或Ang2作用进行药理调节可能有助于通过恢复血管功能、促进组织修复和维持内皮静止来预防或延缓糖尿病血管并发症的发生。在本综述中,我们总结了Ang1和Ang2的作用、它们在糖尿病并发症中的参与情况,以及针对血管生成素的新型治疗策略,以改善代谢紊乱中的血管健康。

相似文献

1
Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes.血管生成素-1和血管生成素-2在代谢紊乱中的作用:恢复糖尿病血管生成高低平衡的治疗策略
J Endocrinol Invest. 2016 Nov;39(11):1235-1246. doi: 10.1007/s40618-016-0502-0. Epub 2016 Jun 25.
2
Fetoplacental regional variations in the expression of angiopoietin-1, angiopoietin-2, and Tie2 in normal-term and near-term pregnancies.足月和近足月妊娠中胎盘胎儿区域血管生成素-1、血管生成素-2和Tie2表达的区域差异
J Matern Fetal Neonatal Med. 2016 Nov;29(21):3421-8. doi: 10.3109/14767058.2015.1136282. Epub 2016 Mar 3.
3
Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.血管生成素-1 和血管生成素-2 的选择性抑制剂对肿瘤血管正常化的相反作用。
Am J Pathol. 2009 Nov;175(5):2159-70. doi: 10.2353/ajpath.2009.090391. Epub 2009 Oct 8.
4
Angiopoietin 2 signal complexity in cardiovascular disease and cancer.血管生成素 2 信号在心血管疾病和癌症中的复杂性。
Life Sci. 2019 Dec 15;239:117080. doi: 10.1016/j.lfs.2019.117080. Epub 2019 Nov 19.
5
Endothelial permeability following coronary artery bypass grafting: an observational study on the possible role of angiopoietin imbalance.冠状动脉旁路移植术后的内皮通透性:关于血管生成素失衡潜在作用的一项观察性研究
Crit Care. 2016 Mar 6;20:51. doi: 10.1186/s13054-016-1238-0.
6
Effect of HIV-1 Infection on Angiopoietin 1 and 2 Levels and Measures of Microvascular and Macrovascular Endothelial Dysfunction.HIV-1 感染对血管生成素 1 和 2 水平及微血管和大血管内皮功能障碍指标的影响。
J Am Heart Assoc. 2021 Nov 16;10(22):e021397. doi: 10.1161/JAHA.121.021397. Epub 2021 Nov 2.
7
Intrinsic differences in the mechanisms of Tie2 binding to angiopoietins exploited by directed evolution to create an Ang2-selective ligand trap.通过定向进化利用 Tie2 与血管生成素结合的机制内在差异来创建 Ang2 选择性配体陷阱。
J Biol Chem. 2021 Aug;297(2):100888. doi: 10.1016/j.jbc.2021.100888. Epub 2021 Jun 18.
8
Orchestral actions of angiopoietin-1 in vascular regeneration.血管生成素-1 在血管再生中的交响乐作用。
Trends Mol Med. 2013 Jan;19(1):31-9. doi: 10.1016/j.molmed.2012.10.010. Epub 2012 Nov 23.
9
Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells.人嗜碱性粒细胞和肥大细胞中血管生成素及其受体的表达和功能。
J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):827-39.
10
Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer.血管生成素-1、血管生成素-2和Tie2基因在有黄体的正常卵巢及卵巢癌中的表达。
Oncology. 2002;62(4):340-8. doi: 10.1159/000065066.

引用本文的文献

1
Exosomes in Diabetic Wound Healing: Mechanisms, Applications, and Perspectives.糖尿病伤口愈合中的外泌体:机制、应用及展望
Diabetes Metab Syndr Obes. 2025 Aug 21;18:2955-2976. doi: 10.2147/DMSO.S532885. eCollection 2025.
2
Research progress on the advantages, mechanisms and design strategies of nanomaterials for immunomodulatory angiogenesis.纳米材料用于免疫调节性血管生成的优势、机制及设计策略的研究进展
Mater Today Bio. 2025 Jul 29;34:102147. doi: 10.1016/j.mtbio.2025.102147. eCollection 2025 Oct.
3
Risk Factors, Pathological Changes, and Potential Treatment of Diabetes-Associated Cognitive Dysfunction.

本文引用的文献

1
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy.5型磷酸二酯酶抑制剂西地那非可降低人心肌细胞及糖尿病心肌病患者体内的促炎趋化因子CXCL10水平。
Inflammation. 2016 Jun;39(3):1238-52. doi: 10.1007/s10753-016-0359-6.
2
PDE5 Inhibition Ameliorates Visceral Adiposity Targeting the miR-22/SIRT1 Pathway: Evidence From the CECSID Trial.PDE5 抑制通过 miR-22/SIRT1 通路改善内脏脂肪:CECSID 试验的证据。
J Clin Endocrinol Metab. 2016 Apr;101(4):1525-34. doi: 10.1210/jc.2015-4252. Epub 2016 Mar 10.
3
The Synthetic Tie2 Agonist Peptide Vasculotide Protects Renal Vascular Barrier Function In Experimental Acute Kidney Injury.
糖尿病相关认知功能障碍的危险因素、病理变化及潜在治疗方法
J Diabetes. 2025 Apr;17(4):e70089. doi: 10.1111/1753-0407.70089.
4
PTEN/PI3K/AKT pathway activation with hypoxia-induced human umbilical vein endothelial cell exosome for angiogenesis-based diabetic skin reconstruction.利用缺氧诱导的人脐静脉内皮细胞外泌体激活PTEN/PI3K/AKT信号通路用于基于血管生成的糖尿病皮肤重建。
Mater Today Bio. 2025 Mar 11;32:101651. doi: 10.1016/j.mtbio.2025.101651. eCollection 2025 Jun.
5
Activation of angiopoietin-1 signaling with engineering mesenchymal stem cells promoted efficient angiogenesis in diabetic wound healing.通过工程化间充质干细胞激活血管生成素-1信号通路可促进糖尿病伤口愈合中的高效血管生成。
Stem Cell Res Ther. 2025 Feb 21;16(1):75. doi: 10.1186/s13287-025-04207-7.
6
Promoting diabetic oral mucosa wound healing with a light-responsive hydrogel adaptive to the microenvironment.利用一种适应微环境的光响应水凝胶促进糖尿病口腔黏膜伤口愈合。
Heliyon. 2024 Sep 28;10(19):e38599. doi: 10.1016/j.heliyon.2024.e38599. eCollection 2024 Oct 15.
7
Advances in tumor vascular growth inhibition.肿瘤血管生长抑制的进展。
Clin Transl Oncol. 2024 Sep;26(9):2084-2096. doi: 10.1007/s12094-024-03432-5. Epub 2024 Mar 20.
8
Adiponectin as a therapeutic target for diabetic foot ulcer.脂联素作为糖尿病足溃疡的治疗靶点。
World J Diabetes. 2023 Jun 15;14(6):758-782. doi: 10.4239/wjd.v14.i6.758.
9
The application and research progress of anti-angiogenesis therapy in tumor immunotherapy.抗血管生成治疗在肿瘤免疫治疗中的应用及研究进展。
Front Immunol. 2023 Jun 2;14:1198972. doi: 10.3389/fimmu.2023.1198972. eCollection 2023.
10
Incubation with porcine urinary bladder matrix yields a late-stage wound transcriptome in endothelial cells and keratinocytes isolated from both diabetic and non-diabetic subjects.与猪膀胱基质孵育可使来自糖尿病和非糖尿病患者的内皮细胞和角质形成细胞的晚期伤口转录组。
Exp Dermatol. 2023 Sep;32(9):1430-1438. doi: 10.1111/exd.14845. Epub 2023 Jun 15.
合成的 Tie2 激动剂肽血管生成素在实验性急性肾损伤中保护肾血管屏障功能。
Sci Rep. 2016 Feb 25;6:22111. doi: 10.1038/srep22111.
4
Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration.视网膜下注射腺相关病毒2型.COMP-血管生成素1可抑制年龄相关性黄斑变性小鼠模型中的脉络膜新生血管形成和血管内皮生长因子。
Exp Eye Res. 2016 Apr;145:248-257. doi: 10.1016/j.exer.2016.01.009. Epub 2016 Jan 13.
5
Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and cAMP Pathways in Vascular Cells.III型磷酸二酯酶抑制剂西洛他唑通过激活血管细胞中的过氧化物酶体增殖物激活受体γ和cAMP途径诱导血管生成
Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):545-52. doi: 10.1161/ATVBAHA.115.307011. Epub 2016 Jan 14.
6
Interleukin-19 and angiopoietin-2 can enhance angiogenesis of diabetic complications.白细胞介素-19和血管生成素-2可增强糖尿病并发症的血管生成。
J Diabetes Complications. 2016 Mar;30(2):386-7. doi: 10.1016/j.jdiacomp.2015.11.002. Epub 2015 Nov 5.
7
A Designed Angiopoietin-1 Variant, Dimeric CMP-Ang1 Activates Tie2 and Stimulates Angiogenesis and Vascular Stabilization in N-glycan Dependent Manner.一种设计的血管生成素-1变体,二聚体CMP-血管生成素-1以N-聚糖依赖性方式激活Tie2并刺激血管生成和血管稳定。
Sci Rep. 2015 Oct 19;5:15291. doi: 10.1038/srep15291.
8
Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic Retinopathy.玻璃体内注射AAV2.COMP-Ang1可预防糖尿病性视网膜病变小鼠模型中的神经血管退变。
Diabetes. 2015 Dec;64(12):4247-59. doi: 10.2337/db14-1030. Epub 2015 Sep 4.
9
Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes.内皮功能障碍标志物作为西地那非治疗的靶点及其对2型糖尿病代谢控制的影响
Expert Opin Ther Targets. 2015;19(12):1617-22. doi: 10.1517/14728222.2015.1066337. Epub 2015 Jul 15.
10
Tumor Necrosis Factor-Alpha and 8-Hydroxy-2'-Deoxyguanosine are Associated with Elevated Urinary Angiopoietin-2 Level in Type 2 Diabetic Patients with Albuminuria.肿瘤坏死因子-α和8-羟基-2'-脱氧鸟苷与2型糖尿病蛋白尿患者尿血管生成素-2水平升高有关。
Kidney Blood Press Res. 2015;40(4):355-65. doi: 10.1159/000368510. Epub 2015 Jun 20.